Last reviewed · How we verify
IV doxapram
Stimulates the central nervous system to increase respiratory rate
Stimulates the central nervous system to increase respiratory rate Used for Respiratory depression.
At a glance
| Generic name | IV doxapram |
|---|---|
| Sponsor | Alexza Pharmaceuticals, Inc. |
| Drug class | Central nervous system stimulant |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 2 |
Mechanism of action
Doxapram works by stimulating the central nervous system to increase respiratory rate, which can be beneficial in patients with respiratory depression.
Approved indications
- Respiratory depression
Common side effects
- Nausea
- Vomiting
- Headache
Key clinical trials
- Doxapram Therapy in Preterm Infants (DOXA Trial) (PHASE3)
- Staccato Alprazolam in Panic Attack (PHASE2)
- The Effect and Mechanism of Respiratory Stimulant Doxapram on Facilitating Emergence (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |